As artificial intelligence (AI) permeates the regulatory world, experts said it won't take over regulatory professionals' ...
<i>Regulatory Focus</i> is the only source of timely, quality news and information fully dedicated to daily online coverage of the global regulation of healthcare products. An experienced team of ...
A top US Food and Drug Administration (FDA) enforcement official announced that the agency conducted more unannounced drug ...
More than 500 comments have been submitted in response to the US Food and Drug Administration’s (FDA) discussion paper on ...
Navigating Europe’s complex environmental and sustainability legislation can be daunting, but healthcare product ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
Sponsored Content] Health Canada’s 14 September 2026 interim policy introduces flexibility in ethics reporting, investigator ...
You are here: Homepage News & Insights Search Regulatory pathways for approving foreign drugs in China: A global integration perspective ...
In a final guidance issued on Monday, the US Food and Drug Administration (FDA) laid out its expectations for cell and gene ...
Patients who reviewed and signed a patient agreement form (PAF) for mifepristone and misoprostol under the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results